Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States
HCPs preferred a pneumococcal vaccine with increased coverage against pneumococcal pneumonia and IPD, and they supported lowering the age recommendation for pneumococcal vaccination as well as a supplemental vaccine dose to provide additional coverage for adults.
Authors
- Ana Martinez
- Jui‐Hua Tsai (ORCID: https://orcid.org/0000-0001-7046-9216)
- Salini Mohanty (ORCID: https://orcid.org/0000-0001-7610-6467)
- Kelly D. Johnson (ORCID: https://orcid.org/0000-0002-4275-6135)
- Elmira Flem (ORCID: https://orcid.org/0000-0002-5099-1960)
- Ning Ning (ORCID: https://orcid.org/0009-0000-5707-1027)
- M. Doyinsola Bailey (ORCID: https://orcid.org/0000-0003-2298-1527)
- Rishi P. Verma (ORCID: https://orcid.org/0000-0002-7561-0466)
- Jordana K. Schmier (ORCID: https://orcid.org/0000-0002-4662-8800)
- Nicole Cossrow (ORCID: https://orcid.org/0009-0006-4982-4547)
- Thomas Weiß (ORCID: https://orcid.org/0000-0002-1312-1018)
- Bianca Chun
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Open Health Systems Laboratory (US)
- Access to Wholistic and Productive Living Institute (US)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1080/14760584.2024.2417393
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.39